Cargando…
SynAI: an AI-driven cancer drugs synergism prediction platform
SUMMARY: The SynAI solution is a flexible AI-driven drug synergism prediction solution aiming to discover potential therapeutic value of compounds in early stage. Rather than providing a finite choice of drug combination or cell lines, SynAI is capable of predicting potential drug synergism/antagoni...
Autores principales: | Yan, Kuan, Jia, Runjun, Guo, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660295/ https://www.ncbi.nlm.nih.gov/pubmed/38023331 http://dx.doi.org/10.1093/bioadv/vbad160 |
Ejemplares similares
-
Chemistry42: An
AI-Driven Platform for Molecular Design
and Optimization
por: Ivanenkov, Yan A., et al.
Publicado: (2023) -
AI vs. AI: Can AI Detect AI-Generated Images?
por: Baraheem, Samah S., et al.
Publicado: (2023) -
A Nudge-Inspired AI-Driven Health Platform for Self-Management of Diabetes
por: Joachim, Shane, et al.
Publicado: (2022) -
Practical AI on the Google Cloud Platform
por: Lanham, Micheal
Publicado: (2020) -
AI-driven designed protein epigenomics
por: Levy, Shiri, et al.
Publicado: (2023)